Insights from Real-World Data: Clinical Features and Treatment Patterns of Compound Jinqiancao Granules in Patients with Prostatitis

This study analyzed the clinical use and medication patterns of Compound Jinqiancao Granules in 1,922 prostatitis patients using data from 20 tertiary hospitals. Most patients were aged 46–65, with hospital stays of 8 to 14 days. Prostatitis was the primary diagnosis, and common co-medications included finasteride and antibiotics. Chinese proprietary preparations were used based on syndrome differentiation. The study found that dosage and administration generally followed drug labeling, but due to the lack of a control group, no conclusions about efficacy or therapeutic effectiveness can be made.